Compare ImmunityBio Inc. Common Stock (IBRX) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Revolution Medicines Inc. Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.01 (market cap $10.33B), while Revolution Medicines Inc. Common Stock trades at $189 (market cap $43.07B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 4.2× ImmunityBio Inc. Common Stock's market cap, and ImmunityBio Inc. Common Stock is more actively traded (11,745,198 versus 1,184,841). Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| IBRX | RVMD | |
|---|---|---|
Market Cap | $10.33B | $43.07B |
Volume | 11,745,198 | 1,184,841 |
Sector | Health | Health |
52-Week High | $11.55 | $221.15 |
52-Week Low | $1.98 | $47.50 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.79B | $39.77B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →
